<acronym>OSU</acronymn> logo  
  <acronym>OSU</acronymn> logo  
<acronym>OSU</acronymn> logo HOMEABOUT THE DEPARTMENTCOURSESDIRECTORYGRADUATE PROGRAMCONTACT US
Home > Department Directory > Faculty > George E. Billman, Ph.D.
 
Department Directory
Faculty
Bruce A. Biagi, Ph.D.
George E. Billman, Ph.D.
Jack A. Boulant, Ph.D.
Jonathan P. Davis, Ph.D.
Jean-Pierre L. Dujardin, Ph.D.
Sandor Gyorke, Ph.D.
Lyn B. Jakeman, Ph.D.
Paul M.L. Janssen, Ph.D.
Sissy M. Jhiang, Ph.D.
Beth S. Lee, Ph.D.
Jen Hill Lucas, Ph.D.
Muthu Periasamy, Ph.D.
Jack A. Rall, Ph.D.
John M. Robinson, Ph.D.
Robert L. Stephens, Jr., Ph.D.
Arthur R. Strauch, III, Ph.D.
Dale D. Vandre, Ph.D.
Sergiy Viatchenko-Karpinski, Ph.D.
Guo-Du Wang, M.D., Ph.D.
Jackie D. Wood, Ph.D.
Mark T. Ziolo, Ph.D.
Adjunct Faculty
Emeritus Faculty
Postdoctoral Researchers
Graduate Students
Research Staff
Administrative Staff

George E. Billman, Ph.D.

Professor

Office - 204 Wiseman Hall
Laboratory - 1005 Wiseman Hall

Mailing Address:
304 Hamilton Hall
1645 Neil Avenue
Columbus OH  43210-1218

billman.1@osu.edu

Billman Picture

Education:
Ph.D., Physiology and Biophysics, University of Kentucky, Lexington, KY

Research Interest:
Cardiovascular physiology; the cardiovascular response to stress (i.e., exercise), the mechanisms responsible for ventricular fibrillation, signal transduction and excitation-contraction coupling during heart failure; cardiovascular effects of dietary omega-3 polyunsaturated fatty acids.

Techniques Available:
Survival surgery, electrocardiogram interpretation, echocardiography, myocyte preparation, calcium transient determinations (fura-2, a calcium sensitive dye), heart rate variability analysis (non-invasive marker of changes in the autonomic neural control of the heart).

Publications (selected):
Billman GE, Kukielka M. Effect of exercise training on heart rate variability and susceptibility to sudden cardiac death: protection is not due to enhanced cardiac vagal regulation. J Appl Physiol 100: 896-906, 2006.
• Kukielka M, Seals DR, Billman GE. Cardiac vagal modulation of heart rate during prolonged submaximal exercise in animals with healed myocardial infarctions: effects of training. Am J Physiol (Heart Circ Physiol) 290: H1680-H1685, 2006.
Billman GE, Kukielka M, Kelley R, M Mustafa-Bayoumi, Altschuld RA. Endurance exercise training attenuates cardiac Beta 2-adrenoceptor responsiveness and prevents ventricular fibrillation in animals susceptible to sudden death. Am J Physiol (Heart Circ Physiol) 290: H2590-H2599, 2006.
Billman GE. Heart rate response to the onset of exercise: evidence for enhanced cardiac sympathetic activity in animals susceptible to ventricular fibrillation. Am J Physiol (Heart Circ Physiol) 291: H429-H435, 2006.
Billman GE. A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development. (Invited Review) Pharmacol & Therap 111: 808-835, 2006.
Billman GE, Kukielka M. Effect of endurance exercise training on the heart rate onset and heart rate recovery responses to submaximal exercise in animals susceptible to ventricular fibrillation. J Appl Physiol 102: 231-240, 2007.
• da Cunha D, Hamlin RL, Billman GE, Carnes CA. n-3 Polyunsaturated fatty acids prevent acute atrial electrophysiologic remodeling. Brit J Pharmacol 150: 281-285, 2007.
• London BS, Albert C, Anderson ME, Giles WR, Van Wagoner DR, Balk E, Billman GE, Chung M, Lands W, McAnulty J, Martens JR, Costello RB, Lathrop DA. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research – a report from the NHLBI and ODS omega-3 fatty acids and the role in cardiac arrhythmogenesis workshop. Circulation 116: e320-e335, 2007.
• Holycross BJ, Kukielka M, Nishijima Y, Altschuld RA, Carnes CA, Billman GE. Exercise training normalizes beta-adrenoceptor expression in dogs susceptible to ventricular fibrillation. Am J Physiol Heart Circ Physiol 293: H2702-H2709, 2007.
Billman GE, Kukielka M. The novel transient outward and ultrarapid rectifier current antagonist, AVE0118, protects against ventricular fibrillation induced by myocardial ischemia. J Cardiovasc Pharmacol (In Press).

Research Funding:
• NIH NHLBI “Dietary Omega-3 Fatty Acids and Sudden Cardiac Death”, 07/01/07-06/30/11, $1,310,236 (direct cost only).
• Sanofi-Aventis Deutschland GmbH “Effects of a Novel Compound on Susceptibility to Ventricular Fibrillation Induced by Myocardial Ischemia in a Conscious Canine Model of Sudden Cardiac Death”, 01/01/05 – 12/31//08, $375,000 (direct cost only).

 

The Ohio State University
Department of Physiology and Cell Biology

304 Hamilton Hall | 1645 Neil Avenue | Columbus, OH. 43210-1218
p: 614.292.2310 | f: 614.292.4888 | Contact Us